Exclusive: Blackstone to test buyout market for PMG's CRO and pharma commercialization divisions, sources say

Blackstone acquired Precision Medicine Group from Berkshire Partners and TPG Growth for between $2.3bn and $2.4bn in late 2020.

FeaturedNorth AmericaUSHealthcareTop Stories